SUNDAY, MAY 31, 2026
9:30am – 10:05am

IBD

KEYNOTE #4:
Dysplasia and Neoplasia in IBD

Session Learning Objectives

• Discuss changing risks of intestinal and extra-intestinal cancers in IBD
• Review the latest guidance and evidence concerning screening and surveillance strategies for colorectal neoplasia in IBD

Speaker:

Dr. Sanjay Murthy, MD, MSc (Epid), FRCPC

Associate Professor, Department of Medicine and School of Epidemiology and Public Health, University of Ottawa
Staff Gastroenterologist, The Ottawa Hospital Inflammatory Bowel Diseases Centre
Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute
Adjunct Scientist, ICES uOttawa

Dr. Murthy is an Associate Professor and Clinician-Scientist in the Department of Medicine at the University of Ottawa and Gastroenterologist at the Ottawa Hospital IBD Centre. He completed his MD at the University of Ottawa, Internal Medicine Training at the University of Manitoba and Gastroenterology Training at the University of Toronto. He has completed advanced fellowships in IBD (Mount Sinai Hospital, Toronto), diagnostic endoscopy (University of Mainz, Germany), clinical nutrition (Toronto General Hospital) and intestinal ultrasound (Brisbane, Melbourne) and an M.Sc. degree in Clinical Epidemiology and Health Care Research (University of Toronto). Dr. Murthy’s clinical practice is in IBD and general gastroenterology. His research program focuses on population-based observational studies, pragmatic trials and clinical prediction models to the study inflammatory bowel diseases and gastrointestinal cancers. He is supported by a Faculty of Medicine Research Chair in IBD from the University of Ottawa.